9-valent HPV vaccine Clinical Trials
2 recruitingBiologic
Phase 31Phase 41
Showing 1–2 of 2 trials
Recruiting
Phase 4
Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years
HPV Infection
Zhejiang Provincial Center for Disease Control and Prevention400 enrolled1 locationNCT07281677
Recruiting
Phase 3
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years
Cervical CancerVaginal CancerVulvar Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd.1,200 enrolled1 locationNCT04895020